Day: July 15, 2023

Algernon Pharmaceuticals Announces Private Placement and Issuance of Shares in Connection with Financial Advisory Agreement

Staff July 15, 2023

VANCOUVER, British Columbia, July 14, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or...

Atlas Global Brands Announces Delay in Annual and Interim Filings Following Complex Reverse Takeover, Acquisitions and Corporate Restructuring

Staff July 15, 2023

CHATHAM, ONTARIO and TEL-AVIV, ISRAEL, July 14, 2023 (GLOBE NEWSWIRE) -- Atlas Global Brands Inc. (“Atlas Global” or the “Company”)...

Red White & Bloom and Aleafia Health Mutually Agree to Terminate Binding Letter Agreement

Staff July 15, 2023

TORONTO, July 14, 2023 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) (“RWB” or...

BridgeBio to Host Investor Call to Share Topline 30-month Results from the Phase 3 ATTRibute-CM Study in Patients with Transthyretin Amyloid Cardiomyopathy on July 17, 2023

Staff July 15, 2023

PALO ALTO, Calif., July 14, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused...

Day: July 15, 2023

Algernon Pharmaceuticals Announces Private Placement and Issuance of Shares in Connection with Financial Advisory Agreement

Atlas Global Brands Announces Delay in Annual and Interim Filings Following Complex Reverse Takeover, Acquisitions and Corporate Restructuring

Red White & Bloom and Aleafia Health Mutually Agree to Terminate Binding Letter Agreement

BridgeBio to Host Investor Call to Share Topline 30-month Results from the Phase 3 ATTRibute-CM Study in Patients with Transthyretin Amyloid Cardiomyopathy on July 17, 2023

Phio Pharmaceuticals Announces Positive Safety Monitoring Committee (SMC) Recommendation to Continue to Third Dose Cohort in its Clinical Study of PH-762

HISENSE UNVEILS NEWEST SMART HOME AND AI INNOVATIONS AT CES 2025

BioNxt Solutions Expands Patent Protection for Drug Delivery Innovations Backed by Positive IPRP

Hemogenyx Pharmaceuticals PLC Announces Ultrafast CAR-T Manufacturing

Pivot Bio Launches New Retail Distribution Partnerships

You may have missed